InvestorsHub Logo
Followers 20
Posts 5416
Boards Moderated 0
Alias Born 01/04/2012

Re: alexs124 post# 8607

Thursday, 02/09/2012 9:42:12 PM

Thursday, February 09, 2012 9:42:12 PM

Post# of 26138
I prefer more accurate math Bio-t-gel has much greater revenue projections then you estimate. Common $1 million that workout $10 - $15 for Teva. I have linked a more realistic projection.

Bio-t-gel

And this only for the US. Biosante still owns the rights to the rest of the world. Teva is in over 60 countries. I see another agreement with Teva for the rest of the world down the road once Bio-t-gel marketing in the US is established.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.